Location of Repository

Brain Apolipoprotein E: an Important Regulator of Food Intake in Rats

By Ling Shen, Patrick Tso, Stephen C. Woods, Deborah J. Clegg, Kyna L. Barber, Katherine Carey and Min Liu

Abstract

OBJECTIVE—The worldwide prevalence of obesity is increasing at an alarming rate, along with the associated increased rates of type 2 diabetes, heart disease, and some cancers. While efforts to address environmental factors responsible for the recent epidemic must continue, investigation into the anorectic functions of potential molecules we present here, such as apolipoprotein (apo)E, offers exciting possibilities for future development of successful anti-obesity therapies

Topics: Obesity Studies
Publisher: American Diabetes Association
OAI identifier: oai:pubmedcentral.nih.gov:2494691
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2008). 2097protects against oxidative stress in mixed neuronal-glial cell cultures by reducing glutamate toxicity. Neurochem Int 44:107–118,
    2. (2000). Apolipoprotein E and atherosclerosis. Curr Opin Lipidol 11:243–251,
    3. (1985). Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system.
    4. (2005). Apolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase.
    5. (1988). Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.
    6. (2006). Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer’s disease. Proc Natl Acad SciUSA103:18787–18792,
    7. (2001). Cowburn RF: Apolipoprotein E: a major piece in the Alzheimer’s disease puzzle.
    8. (1999). CV: Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin. Endocrinology 140:4551–4557,
    9. (2000). DG: Central nervous system control of food intake.
    10. (1997). Dietary fat and chronic diseases: epidemiologic overview.
    11. (1997). F: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131–141,
    12. (1996). Friedman JM: Abnormal splicing of the leptin receptor in diabetic mice.
    13. (2004). Functions of lipoprotein receptors in neurons.
    14. (2004). Gastrointestinal satiety signals. I. An overview of gastrointestinal signals that influence food intake.
    15. (2001). Heiman ML: Rodent obesity models: an overview. Exp Clin Endocrinol Diabetes 109:307–319,
    16. (1975). Isolation and partial characterization of an arginine-rich apolipoprotein from human plasma very-low-density lipoproteins: apolipoprotein E. Hoppe Seylers Z Physiol Chem 356:1113–1121,
    17. (1996). JP: Evidence that the diabetes gene encodes the leptin receptor: identifi-cation of a mutation in the leptin receptor gene in db/db mice. Cell 84:491–495,
    18. (1998). Leptin and the regulation of body weight in mammals.
    19. (2002). RC: LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice.
    20. (1998). Saper CB: Distributions of leptin receptor mRNA isoforms in the rat brain.
    21. (1995). SC: A comparison between effects of intraventricular insulin and intraperitoneal lithium chloride on three measures sensitive to emetic agents.
    22. (1998). Schwartz MW: Signals that regulate food intake and energy homeostasis. Science 280:1378–1383,
    23. (1998). SL: Dietary fat consumption and health. Nutr Rev 56:S3–S19,
    24. (2002). SL: Effects of adrenalectomy on AGRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats. Brain Res 958:130–138,
    25. (1999). The central melanocortin system and energy homeostasis. Trends Endocrinol Metab 10:211–216,
    26. (2003). Tso P: A controlled high-fat diet induces an obese syndrome in rats.
    27. (2004). Tso P: Diurnal rhythm of apolipoprotein A-IV in rat hypothalamus and its relation to food intake and corticosterone. Endocrinology 145:3232–3238,
    28. (2003). Tso P: Expression of biologically active rat apolipoprotein AIV in Escherichia coli. Physiol Behav 78:149–155,
    29. (1990). Tso P: Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat.
    30. (1997). WD: Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor.
    31. (2006). Woods SC: Apolipoprotein A-IV interacts synergistically with melanocortins to reduce food intake. Am J Physiol Regul Integr Comp Physiol 290:R202–R207,

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.